<p>DINGDANG HEALTH (09886.HK) announced its 2025 annual results, with revenue reaching 4.888 billion RMB, an increase of 4.7% year-on-year. The loss narrowed from 376 million RMB in the previous year to 49.02 million RMB, with a loss per share of 0.04 RMB. No final dividend is declared</p>

510660

09886

159929

516610

512010

513120

589720

<p>DINGDANG HEALTH announced its 2025 annual performance, with revenue recorded at 4.888 billion RMB, an increase of 4.7% year-on-year. The loss narrowed from 376 million RMB in the previous year to 49.02 million RMB, with a loss per share of 0.04 RMB. No final dividend will be distributed</p>

AASTOCKS

ChinaAMC SSE Health Care ETF Initiating Fund

DINGDANG HEALTH

China Universal 800 Health Care ETF

Dacheng CSI All Share Health Care Equipment and Services ETF

E Fund CSI 300 Health Care ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Guotai SSE STAR Brand Name Drug ETF

"DINGDANG HEALTH" narrowed its annual loss to 49.02 million RMB